Lv614
1664 积分 2024-09-28 加入
Current status and quality of radiomic studies for predicting immunotherapy response and outcome in patients with non-small cell lung cancer: a systematic review and meta-analysis
27天前
已完结
Structure–function–rescue: the diverse nature of common p53 cancer mutants
2个月前
已完结
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
2个月前
已完结
TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
2个月前
已完结
IARC p53 mutation database: A relational database to compile and analyze p53 mutations in human tumors and cell lines
2个月前
已完结
Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy
2个月前
已完结
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
2个月前
已完结
P1.07.43 Clinico-Genomic Correlates of Pathologic Response to Neoadjuvant Chemo-Immunotherapy in Patients With Early-Stage NSCLC
5个月前
已关闭
Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing
5个月前
已完结
P1.11.28 Nomogram and Effectiveness of Bone-Modifying Agents in Advanced Driver-Negative NSCLC: A Retrospective Real-World Study
5个月前
已关闭
皖公网安备34019202002308
